Jeffrey Farrow
2023 - Tarsus Pharmaceuticals
In 2023, Jeffrey Farrow earned a total compensation of $4M as Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $241,200 |
| Option Awards | $1,590,572 |
| Salary | $343,751 |
| Stock Awards | $1,678,310 |
| Other | $37,997 |
| Total | $3,991,830 |
Farrow received $1.7M in stock awards, accounting for 42% of the total pay in 2023.
Farrow also received $100K in bonus, $241.2K in non-equity incentive plan, $1.6M in option awards, $343.8K in salary and $38K in other compensation.
Rankings
In 2023, Jeffrey Farrow's compensation ranked 188th out of 3,006 executives tracked by ExecPay. In other words, Farrow earned more than 93.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 188 out of 3,006 | 94th |
Division Manufacturing | 99 out of 1,650 | 94th |
Major group Chemicals And Allied Products | 63 out of 918 | 93rd |
Industry group Drugs | 62 out of 881 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 21 out of 213 | 90th |
Source: SEC filing on April 26, 2024.
Farrow's colleagues
We found three more compensation records of executives who worked with Jeffrey Farrow at Tarsus Pharmaceuticals in 2023.